Table 5. Treatment and clinical outcome of MRSA and MSSA keratitis.

	MRSA (n = 26)	MSSA (n = 33)	P value
Administration of topical antibiotics: n (%)	26 (100)	33 (100)
Modification of antibiotics: n (%)	17 (65.4)	15 (45.5)	0.057
Surgical intervention: n (%)	9 (34.6)	9 (27.3)	0.543
Admission: n (%)	13 (50)	14 (44.4)	0.922*
Severe complications:† n (%)	4 (15.4)	4 (12.1)	0.722*
Healing time‡ (months)median (mini∼max)	1.2 (0.2∼8.5)	0.83 (0.1∼11.7)	0.348
VA (Log MAR): median (mini∼max)
At presentation	2.6 (0∼3)	1.65 (0∼3)	0.084
After treatment	2.3 (0∼3.2)	1.7 (0∼3.2)	0.449

^*: P value obtained by Fisher's Exact Test.

^†: Severe complications: corneal perforation and/or endophthalmitis.

^‡: Healing time: defined as the resolution of infiltration and epithelial defect.

MRSA: methicillin-resistant Staphylococcus aureus, MSSA: methicillin-sensitive Staphylococcus aureus, VA: visual acuity, Log MAR : logarithm of the minimum angle.